<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02756598</url>
  </required_header>
  <id_info>
    <org_study_id>SATA-1</org_study_id>
    <nct_id>NCT02756598</nct_id>
  </id_info>
  <brief_title>Stress, Anxiety and Type A Personality and Analgesics</brief_title>
  <acronym>SATA-1</acronym>
  <official_title>Stress, Anxiety and Type A Personality and Analgesics. Impact on Induction Time and Consumption of Analgesics During Cardiac Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aarhus University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aarhus University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients scheduled for elective cardiac surgery are preoperative evaluated using different
      personality type, stress and anxiety tests.

      Patient are randomized to receive the investigators' standard moderate dose sufentanil (bolus
      1microgram/kg and propofol 0.03 mg/kg/min) or low dose sufentanil (bolus 0.5 microgram/kg and
      propofol 0.06 mg/kg/min).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients randomized and the type of induction informed to the anaesthetist 30 minutes before
      surgery.

      Patients are monitored before induction of anesthesia. Propofol is started on the randomized
      infusion rate. Sufentanil bolus are given according to randomization. BIS level is followed.
      Time to reach BIS &lt; 50 is monitored. BIS after 30, 60 and 90 minutes are registered. Lowest
      BIS during surgery are registered. Total amounts of sufentanil and propofol recorded.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">January 2015</start_date>
  <completion_date type="Anticipated">May 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Association between preoperative personality/stress/anxiety and time (minutes) to reach anaesthetic depth goal by bi-spectral index (BIS)</measure>
    <time_frame>Up to 30 minutes</time_frame>
    <description>Minutes to reach BIS 50</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Potential of sufentanil regime on fast-track measured by ventilation time and association with eligible discharge from intensive care unit.</measure>
    <time_frame>Up to 24 hours</time_frame>
    <description>Postoperative ventilation time (hours/minutes) and the association to eligible discharge from ICU.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sufentanil regime and association to haemodynamic parameters (blood pressures, heart rate, cardiac output, oxygenation)</measure>
    <time_frame>up to 24 hours</time_frame>
    <description>Perioperative changes in haemodynamic parameters (analysis of varians) of haemodynamic parameters according to sufentanil regime</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Association between preoperative personality/stress/anxiety tests and postoperative care using postoperative quality score</measure>
    <time_frame>up to 24 hours</time_frame>
    <description>Association of preoperative tests and the postoperative ICU quality scoring</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Association between preoperative personality/stress/anxiety and total amounts of sufentanil and propofol</measure>
    <time_frame>Up to 12 hours</time_frame>
    <description>Amounts of drugs as pr kg pr time unit of involved drugs</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Postoperative; Dysfunction Following Cardiac Surgery</condition>
  <arm_group>
    <arm_group_label>Sufentanil I</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Randomized arm &quot;moderate&quot; sufentanil I: bolus 1 microgram/kg propofol I: infusion 0.03 mg/kg/min</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sufentanil II</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Randomized arm &quot;low&quot; sufentanil II bolus 0.5 microgram/kg propofol II: infusion 0.06 mg/kg/min</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sufentanil I</intervention_name>
    <description>bolus dose of sufentanil 1 microgram/kg</description>
    <arm_group_label>Sufentanil I</arm_group_label>
    <other_name>Sufenta</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sufentanil II</intervention_name>
    <description>bolus dose of sufentanil 0.5 microgram/kg</description>
    <arm_group_label>Sufentanil II</arm_group_label>
    <other_name>Sufenta</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol I</intervention_name>
    <description>Continued dose of propofol 0.03 mg/kg/min</description>
    <arm_group_label>Sufentanil I</arm_group_label>
    <other_name>Propofol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol II</intervention_name>
    <description>Continued dose of propofol 0.06 mg/kg/min</description>
    <arm_group_label>Sufentanil II</arm_group_label>
    <other_name>Propofol</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All elective cardiac surgery patients

        Exclusion Criteria:

          -  Patients requiring special attention or monitoring during induction

          -  Patients with expected longer postoperative ventilation time

          -  Patients allergic to sufentanil and or propofol

          -  Participation in other projects

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 30, 2015</study_first_submitted>
  <study_first_submitted_qc>April 27, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 29, 2016</study_first_posted>
  <last_update_submitted>January 24, 2017</last_update_submitted>
  <last_update_submitted_qc>January 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aarhus University Hospital</investigator_affiliation>
    <investigator_full_name>Carl-Johan Jakobsen</investigator_full_name>
    <investigator_title>Consultant Anesthesiologist, Ass professor</investigator_title>
  </responsible_party>
  <keyword>sufentanil</keyword>
  <keyword>propofol</keyword>
  <keyword>personality/stress test</keyword>
  <keyword>fast-track</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Sufentanil</mesh_term>
    <mesh_term>Analgesics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

